Abstract
Carex baccans is used extensively as food additive for its medicinal and nutritional properties. Its extract demonstrated significant inhibition of α-glucosidase and α-amylase with IC50 43.32±1.22 and 562.18±5.98μg/mL, respectively. A bio-assay guided approach was employed to identify the active constituent(s). Fractionation and purification of the extract led to the isolation of a potent inhibitor, (+)-α-viniferin, and of weak inhibitors smiglasides A and B. (+)-α-Viniferin was quantified in the extract and fractions using HPLC and the method was validated for linearity, limit of detection, limit of quantification, precision, and accuracy. The calibration curve showed good linearity (r2>0.999) in the range of 7.813–250μg/mL. The identification of α-glucosidase and α-amylase inhibitory activity in C. baccans supports the possible use of the plant as functional food for the management of diabetes. The validated HPLC method for the study of plant extracts will be useful in future research.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have